• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年乙型肝炎病毒感染者肝细胞癌的预后和预测因素。

Prognosis and predictors of hepatocellular carcinoma in elderly patients infected with hepatitis B virus.

机构信息

Department of Hepatology, Toranomon Hospital, Tokyo, Japan.

出版信息

J Med Virol. 2017 Dec;89(12):2144-2148. doi: 10.1002/jmv.24890. Epub 2017 Aug 31.

DOI:10.1002/jmv.24890
PMID:28667756
Abstract

With rapidly aging population in the world, many elderly patients present with hepatitis B virus (HBV) infection. We conducted a retrospective cohort study involving 359 untreated HBV patients aged 60 and older who were free of hepatocellular carcinoma (HCC) and acute hepatitis at the initial visit, and examined the incidence of HCC and liver-related mortality rate. During the follow-up period of 7.9 years (range, 0-25 years), 26 patients (7.2% of patients) developed HCC, 20 patients died from liver-related diseases (61% of total deaths), including HCC, liver failure, and gastrointestinal bleeding. The cumulative rates of HCC at years 5, 10, and 15 were 6.5%, 15.6%, and 15.6%, respectively. The cumulative rates of mortality from liver-related diseases at years 5, 10, 15 were 3.3%, 12.3%, and 15.7%, respectively. Multivariate analysis identified HBV DNA (≥5.0 Log IU/mL), male gender, and FIB4-Index (≥3.6) as significant independent risk factors for HCC, and alpha-fetoprotein (≥10 ng/mL) as significant independent predictors of liver-related mortality. We conclude that high levels of HBV DNA, progression of liver fibrosis, and male gender are independent risk factors of HCC in untreated patients infected with HBV aged 60 and older.

摘要

随着世界人口的迅速老龄化,许多老年患者患有乙型肝炎病毒 (HBV) 感染。我们进行了一项回顾性队列研究,涉及 359 名未经治疗的 HBV 患者,年龄均在 60 岁及以上,且在初次就诊时无肝细胞癌 (HCC) 和急性肝炎,并检查了 HCC 的发病率和肝脏相关死亡率。在 7.9 年的随访期间(范围为 0-25 年),26 名患者(7.2%的患者)发生 HCC,20 名患者死于肝脏相关疾病(总死亡人数的 61%),包括 HCC、肝功能衰竭和胃肠道出血。5 年、10 年和 15 年时 HCC 的累积发生率分别为 6.5%、15.6%和 15.6%。5 年、10 年和 15 年时肝脏相关疾病死亡率的累积发生率分别为 3.3%、12.3%和 15.7%。多变量分析确定 HBV DNA(≥5.0 Log IU/mL)、男性和 FIB4 指数(≥3.6)是 HCC 的显著独立危险因素,而甲胎蛋白(≥10ng/mL)是肝脏相关死亡率的显著独立预测因子。我们的结论是,未经治疗的 HBV 感染且年龄在 60 岁及以上的患者中,HBV DNA 水平高、肝纤维化进展和男性是 HCC 的独立危险因素。

相似文献

1
Prognosis and predictors of hepatocellular carcinoma in elderly patients infected with hepatitis B virus.老年乙型肝炎病毒感染者肝细胞癌的预后和预测因素。
J Med Virol. 2017 Dec;89(12):2144-2148. doi: 10.1002/jmv.24890. Epub 2017 Aug 31.
2
Natural history of chronic hepatitis B REVEALed.慢性乙型肝炎的自然史被揭示。
J Gastroenterol Hepatol. 2011 Apr;26(4):628-38. doi: 10.1111/j.1440-1746.2011.06695.x.
3
Non-invasive tests for liver disease severity and the hepatocellular carcinoma risk in chronic hepatitis B patients with low-level viremia.用于低病毒载量慢性乙型肝炎患者肝脏疾病严重程度和肝细胞癌风险的非侵入性检测方法。
Liver Int. 2018 Jan;38(1):68-75. doi: 10.1111/liv.13489. Epub 2017 Jul 3.
4
Risk and predictors of hepatocellular carcinoma for chronic hepatitis B patients with newly developed cirrhosis.慢性乙型肝炎合并新发肝硬化患者肝细胞癌的风险及预测因素
J Gastroenterol Hepatol. 2016 Dec;31(12):1971-1977. doi: 10.1111/jgh.13422.
5
Hepatocellular carcinoma risk in chronic hepatitis B virus-infected compensated cirrhosis patients with low viral load.慢性乙型肝炎病毒感染代偿性肝硬化患者低病毒载量与肝细胞癌风险。
Hepatology. 2015 Sep;62(3):694-701. doi: 10.1002/hep.27889. Epub 2015 Jul 3.
6
Incidence of development of hepatocellular carcinoma in Japanese patients infected with hepatitis B virus is equivalent between genotype B and C in long term.在长期随访中,感染乙型肝炎病毒的日本患者中乙型肝炎病毒基因型 B 和 C 发展为肝细胞癌的发生率相当。
J Viral Hepat. 2019 Jul;26(7):866-872. doi: 10.1111/jvh.13099. Epub 2019 Apr 23.
7
Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.隐匿性乙型肝炎病毒感染和既往乙型肝炎病毒感染对丙型肝炎病毒所致肝硬化患者肝细胞癌发生的影响
Scand J Gastroenterol. 2008;43(7):849-56. doi: 10.1080/00365520801935459.
8
What can we learn from hepatitis B virus clinical cohorts?从乙型肝炎病毒临床队列中我们可以学到什么?
Liver Int. 2015 Jan;35 Suppl 1:91-9. doi: 10.1111/liv.12716.
9
Influence of viral load and genotype in the progression of Hepatitis B-associated liver cirrhosis to hepatocellular carcinoma.病毒载量和基因型对乙型肝炎相关性肝硬化进展为肝细胞癌的影响。
Liver Int. 2005 Apr;25(2):220-5. doi: 10.1111/j.1478-3231.2005.01077.x.
10
Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma.丙型肝炎病毒感染与肝细胞癌风险增加相关。
Gut. 2004 Oct;53(10):1494-8. doi: 10.1136/gut.2003.033324.

引用本文的文献

1
Prevalence and Risk Factors of Hepatocellular Carcinoma in Patients Co-infected With Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV): A Cross-Sectional Retrospective Study.乙型肝炎病毒(HBV)和丙型肝炎病毒(HCV)合并感染患者肝细胞癌的患病率及危险因素:一项横断面回顾性研究
Cureus. 2025 Jun 14;17(6):e85985. doi: 10.7759/cureus.85985. eCollection 2025 Jun.
2
A Novel Nomogram to Predict Prognosis in Elderly Early-Stage Hepatocellular Carcinoma Patients After Ablation Therapy.一种预测老年早期肝细胞癌患者消融治疗后预后的新型列线图。
J Hepatocell Carcinoma. 2024 May 17;11:901-911. doi: 10.2147/JHC.S459250. eCollection 2024.
3
Oncological prognosis and morbidity of hepatectomy in elderly patients with hepatocellular carcinoma: a propensity score matching and multicentre study.
老年肝细胞癌患者肝切除术后的肿瘤学预后和发病率:倾向评分匹配和多中心研究。
BMC Surg. 2023 Oct 24;23(1):323. doi: 10.1186/s12893-023-02230-0.
4
How to Effectively Monitor Aging Patients with Chronic Hepatitis B: A Review.如何有效监测慢性乙型肝炎老年患者:综述。
Clin Interv Aging. 2022 Dec 9;17:1811-1820. doi: 10.2147/CIA.S366255. eCollection 2022.
5
Prognostic Analysis of Postoperative Survival for Ruptured Hepatocellular Carcinoma with or without Cirrhosis.伴或不伴肝硬化的破裂肝细胞癌术后生存的预后分析
J Oncol. 2022 Mar 17;2022:7531452. doi: 10.1155/2022/7531452. eCollection 2022.
6
Recent Advances in Anticancer Activity of Novel Plant Extracts and Compounds from Curcuma longa in Hepatocellular Carcinoma.新型姜黄属植物提取物及化合物在肝癌中抗癌活性的最新进展
J Gastrointest Cancer. 2023 Jun;54(2):368-390. doi: 10.1007/s12029-022-00809-z. Epub 2022 Mar 14.
7
Nomogram for Predicting the Prognoses of Patients With Pancreatic Head Cancer After Pancreaticoduodenectomy: A Population-Based Study on SEER Data.预测胰头癌患者胰十二指肠切除术后预后的列线图:一项基于监测、流行病学和最终结果(SEER)数据的人群研究
Front Oncol. 2021 Nov 4;11:766071. doi: 10.3389/fonc.2021.766071. eCollection 2021.
8
Risk Factors, Pathogenesis, and Strategies for Hepatocellular Carcinoma Prevention: Emphasis on Secondary Prevention and Its Translational Challenges.肝细胞癌预防的风险因素、发病机制及策略:重点关注二级预防及其转化挑战
J Clin Med. 2020 Nov 25;9(12):3817. doi: 10.3390/jcm9123817.
9
Xiao Chai Hu Tang, a herbal medicine, for chronic hepatitis B.小柴胡汤,一种草药,用于治疗慢性乙型肝炎。
Cochrane Database Syst Rev. 2019 Nov 7;2019(11):CD013090. doi: 10.1002/14651858.CD013090.pub2.
10
Comparison of tenofovir and entecavir on the risk of hepatocellular carcinoma and mortality in treatment-naïve patients with chronic hepatitis B in Korea: a large-scale, propensity score analysis.比较替诺福韦和恩替卡韦在韩国未经治疗的慢性乙型肝炎患者中对肝细胞癌和死亡率的风险:一项大规模的倾向评分分析。
Gut. 2020 Jul;69(7):1301-1308. doi: 10.1136/gutjnl-2019-318947. Epub 2019 Oct 31.